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Abstract. The use of indocyanine green ICG, a U.S. Food and Drug
Administration approved dye, in a pump-probe scheme for molecular
contrast optical coherence tomography MCOCT is proposed and
demonstrated for the first time. In the proposed pump-probe scheme,
an optical coherence tomography OCT scan of the sample contain-
ing ICG is first acquired. High fluence illumination 190 kJ/cm2 is
then used to permanently photobleach the ICG molecules—resulting
in a permanent alteration of the overall absorption of the ICG. A sec-
ond OCT scan is next acquired. The difference of the two OCT scans
is used to determine the depth resolved distribution of ICG within a
sample. To characterize the extent of photobleaching in different ICG
solutions, we determine the cumulative probability of photobleach-
ing, B,cum, defined as the ratio of the total photobleached ICG mol-
ecules to the total photons absorbed by the ground state molecules.
An empirical study of ICG photobleaching dynamics shows that
B,cum decreases with fluence as well as with increasing dye concen-
tration. The quantity B,cum is useful for estimating the extent of pho-
tobleaching in an ICG sample MCOCT contrast for a given fluence
of the pump illumination. The paper also demonstrates ICG-based
MCOCT imaging in tissue phantoms as well as within stage 54 Xeno-
pus laevis. © 2006 Society of Photo-Optical Instrumentation Engineers.
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Optical coherence tomography1 OCT is an important nonin-
vasive biomedical tool for high resolution2 imaging of bio-
logical samples to a depth of a few millimeters. Since its
inception, OCT has matured into a useful diagnostic tool for
ophthalmic applications.3–6 OCT’s applications for imaging
other areas of the human body include endoscopic imaging of
the gastrointestinal GI tract7 and bladder8 for tumor detec-
tion, monitoring and risk assessment of vulnerable lipid
plaques in the vascular system,9 monitoring intracoronary
stenting,10 and tracking structural weakness associated with
tooth decay.11 While basic OCT imaging is able to render
depth resolved structural images of the target, more sophisti-
cated OCT imaging strategies can provide additional func-
tional information such as flow through Doppler OCT,12 tis-
sue structural arrangement through birefringence OCT,13
and depth resolved spectral signatures through spectral
OCT.14,15 In recent years, a new and exciting functional OCT
method, known as molecular contrast optical coherence to-
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the major advantages of fluorescence microscopy chemical
or biological contrast agent’s detection and imaging capabil-
ity and OCT higher spatial resolution and depth penetra-
tion.
In this paper, we explore the use of indocyanine green
ICG, which is used in medical diagnostics25 and photody-
namic therapy,26 in a MCOCT scheme based on the pho-
tobleaching mechanism of the dye. This work differs in its
contrast mechanism from an earlier work with ICG in a
MCOCT scheme, where the contrast agent’s distribution in-
side the sample was determined from agent’s spectral differ-
ential absorption.21
Aqueous solutions of ICG degrade over time; the process
is accelerated in the presence of light with spectral band that
is coincident with the ICG optical absorption peak. This deg-
radation is attributable to the photobleaching of the ICG. In
addition to the ground and first excited states, ICG has three
states of interest, namely the triplet T, P-isomer P, and
bleached B states, in which the molecules can reside see
Fig. 1. An excited molecule will generally relax directly back
into the ground state, but it does have a small probability of1083-3668/2006/115/054017/12/$22.00 © 2006 SPIE
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and B of the three states are very low 10−5 to 10−6.27 The
pump-probe MCOCT scheme makes use of the fact that mol-
ecules that are temporarily shelved for the case of triplet and
P-isomer states or permanently bleached for the case of
bleached state have a different absorption spectrum from
ground state molecules to elicit contrast. We note that rela-
tively short lifetimes associated with the triplet and P-isomer
states triplet state lifetime, T700 s and P-isomer state
lifetime, P10 ms27 will require elaborate pump-probe
schemes for contrast data acquisition. In comparison, the per-
manency of the photobleached state is appealing in that given
enough time, all the molecules in an illuminated sample of
ICG solution can be transitioned into the bleached state; there
is no stringent pump intensity requirements or fast signal ac-
quisition scheme requirements in this case.
The implementation scheme based on the use of pho-
tobleaching can be summarized as follows. A baseline OCT
scan of the sample containing a contrast agent is first ac-
quired, followed by photoillumination of the sample. The
photoillumination excites the molecules and repeatedly cycles
the molecules through the ground-excited state transition. The
molecules have a small chance of ending up in the pho-
tobleached state during each transition; as such, given a high
enough fluence, the majority of the molecules will eventually
end up in the photobleached state. A second OCT scan is then
acquired. The two OCT scans, which are different as the ab-
sorption spectrum of the contrast agent has changed, are thus
processed to determine the distribution of the contrast agent
within the sample. This paper provides an understanding of
the ICG dynamics in the proposed pump-probe scheme and
demonstrates the MCOCT technique in tissue phantoms as
well as in an animal model.
Since the proposed pump-probe scheme uses the pho-
tobleached state, it is important to understand and quantify the
photobleaching mechanism in ICG. Most notable among pre-
vious works on the photodegradation process in ICG is the
work of Holzer et al.28 The study, however, is based on either
very low e.g., 10 M or very high e.g., 1.5 mM—toxic
level29 concentrations of ICG. Moreover, the work was pre-
dominantly geared toward characterizing the stability of
above two concentrations of ICG in different solvents based
on the initial probability of photobleaching. In this work, we
Fig. 1 Schematic of electronic state diagram of ICG. G is the ground
state absorption cross section, whereas T, P, and B are quantum
yields of triplet T, P-isomer P, and bleached B states.have studied moderate e.g., 10 to 140 M concentra-
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tion of the initial probability of photobleaching changes with
different ICG concentration and the dependency of the prob-
ability of photobleaching on light fluence. We will like to note
that it is the cumulative probability of photobleaching that is
needed to estimate the time required to photobleach a given
ICG sample with a specified irradiance. Therefore, the initial
probabilities such as the ones reported for 10 or 1.5 mM ICG
concentrations in Ref. 28 cannot be used to accurately esti-
mate the photobleaching extent of 200 and 400 M ICG con-
centrations used in the demonstration of proposed pump-
probe–based MCOCT scheme.
This paper is divided into six sections. In Sec. 2, we will
report on our experimental characterizations of the pho-
tobleaching mechanism. In Sec. 3, we will elaborate on the
computation scheme by which we will extract MCOCT infor-
mation from our experimental data. In Sec. 4, we will de-
scribe the MCOCT experiment and report on our experimen-
tal findings. In Sec. 5, we will discuss the adaptation of this
MCOCT scheme for clinical applications. Finally, we will
conclude with a summary of our findings.
2 Photobleaching Dynamics of ICG
As an initial step in the study of the photobleaching dynamics
of ICG, we performed a simple experiment to verify the sta-
bility of the photobleached state. Glass cuvettes from Starna
Cells, Inc. with 1 cm path length were filled with 50 M
ICG SDB8662, H. W. Sands Corp. solutions in 1% bovine
serum albumin BSA and water, and exposed to 790 nm il-
lumination incident optical power 1.2 W for several
hours. Figures 2a to 2c show absorption cross-section
spectra as well as photographs of both unbleached and
bleached samples of 50 M ICG in BSA and water. Notice
that the unbleached samples of ICG solution in BSA and wa-
ter are both green in color. However, the bleached samples of
ICG solution in BSA and water possess shades of orange and
gray, respectively. The bleached samples of ICG in BSA and
water were also observed over several days to see if any re-
covery of the dye from its bleached state had occurred. For
this purpose, the bleached samples were kept in the dark and
two additional sets of absorption spectra were acquired—one
on the third day, and the other on the fifth day see Figs. 2d
and 2e. A quantitative comparison of the measured absorp-
tion spectra of bleached ICG samples shows no signs of re-
covery from the bleached state, which confirms that the pho-
tobleached state is permanent. The permanence of ICG
photobleaching illustrates the usefulness of bleached state
transition in a pump-probe scheme for OCT—the focus of this
study. We note that the extent of change in absorption cross
section =G−B, where G and B are the ground state
and bleached state absorption cross sections, respectively, is a
useful parameter to estimate achievable contrast from a given
ICG sample. From Fig. 2a, it can be seen that ICG solution
in BSA shows a higher contrast change compared to that in
water. This observation, along with the fact that ICG shows
high affinity to bind with proteins,27 indicates that higher con-
trast should be expected from tissue locales where ICG is
attached to proteins provided the ICG samples are completely
bleached.
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dynamics of ICG. A fraction of the collimated beam from a
Ti:sapphire laser Spectra Physics Tsunami, Model 3941-
X3BB is redirected using a beamsplitter BS to form the
reference beam. The major portion of the light signal beam
passes straight through a square cuvette with 2 mm diam-
eter circular hole. Glass cover slips are used on each side to
hold the ICG samples. The path length L of the specially
designed circular cross-section cuvette is 1.52 mm see Fig.
3. Notice that the diameter of the incident collimated laser
beam is approximately the size of the circular hole to reduce
effects due to diffusion. A balanced photodetector New Fo-
cus, Inc. is used to measure the transmission through the ICG
samples over time. Since, a ICG shows high affinity to bind
with proteins which would be the case if injected into a pro-
tein environment and b agarose was used to reduce the
effects due to diffusion in the proof-of-concept demonstra-
tions, 50 M ICG solutions were prepared in deionized DI
Fig. 2 Shows a absorption cross-section spectra and b and c pictu
ICG concentration is 50 M in all the cases. d and e show abso
acquired at different times. F: fresh; BS: bleached sample.water, 1% BSA, and 0.8% agarose for initial study. ICG so-
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DI water. Transmission time traces were acquired for different
irradiance levels ranging from 25 W/cm2 to 80 W/cm2.
Before each transmission measurement, the system was bal-
anced or calibrated by using the corresponding solvent wa-
ter, agarose, or BSA in an identical cuvette and adjusting the
free-space attenuators A1 and A2 accordingly. Note that fresh
samples of ICG were used for each transmission measure-
ment. Figures 4a–4c show the transmission time traces of
50 M ICG in water, 1% BSA, and 0.8% agarose, respec-
tively, for different irradiance levels. A visual inspection of
the transmission curves in Fig. 4 suggests that ICG solution in
BSA shows a higher transmission change when bleached
compared to ICG solution in water or agarose. This finding is
consistent with the  values for ICG in water and 1% BSA,
derived from absorption spectra shown in Fig. 2a.
The absorption of ICG does not change linearly with con-
centration. This is due to the fact that ICG tends to aggregate
nbleached as well as bleached samples of ICG in 1% BSA and water.
spectra of bleached samples of ICG in BSA and water, respectively,res of u
rptionin water at higher concentrations; aggregated ICG molecules
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less, Beer’s law would still be valid if the absorption cross
section were known for a given wavelength and ICG concen-
tration N0. Assuming that the absorption cross sections of the
ground and bleached states do not change during the pho-
tobleaching process, the bleached state population density
NBt can be written as
NBt =
1
G − BL
ln TtTmin , 1
where L is the sample path length and Tt is the transmit-
tance the ratio of transmitted light intensity to the input light
intensity. Tmin=exp−GN0L is the minimum transmittance
at t=0, where N0 is the initial concentration of ICG. Because
the irradiance decays through the sample, NBt, in Eq. 1
represents the spatial average of the bleached state population
density. Therefore, the probability of photobleaching, defined
as the ratio of total number of photobleached molecules to the
total number of photons absorbed by ground state molecules,
can be mathematically expressed as
B,cumt =
NBt V

0
t
P0
h 1 − TGd
, 2
where V is the volume of the ICG sample, h is Planck’s con-
stant,  is the optical frequency of illumination, P0 is the
incident optical power, and TGt=Tmin expGNBL is the
transmittance attributed to ground state ICG molecules. It can
be seen from Eq. 2 that the probability of photobleaching is
a function of time unless the terms in the numerator and de-
nominator vary in a similar fashion in time. Moreover, this
approach yields a probability that is cumulative in nature such
that at a given time t, B,cumt gives an average probability
of photobleaching for time interval 0, t.
The transmission data shown in Fig. 4 were processed to
determine the cumulative probability of photobleaching,
B,cum, using Eqs. 1 and 2. The cumulative probability of
photobleaching was determined for each data set and aver-
aged. Figure 5 shows average B,cum versus fluence for
50 M ICG in water, 1% BSA, and 0.8% agarose; the corre-
Fig. 3 Experimental setup to study ICG photodegradation dynamics.
BS: beamsplitter; M: mirror; Ai: i’th attenuator; R: reference beam; S:
sample beam.sponding initial cumulative probabilities, B,cum,init, were de-
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0.8±0.310−5, respectively. This empirical study also il-
lustrates that B,cum decreases with fluence. For instance, in
the case of 50 M ICG in water, the probability of pho-
tobleaching decreased by 1/3 of the corresponding
B,cum,init value at 1 kJ/cm2 fluence. Moreover, the rate at
which the cumulative probability of photobleaching decreases
Fig. 4 Transmission curves for 50 M ICG versus time in a DI water,
b 1% BSA, and c 0.8% agarose for different illumination intensities
irradiance levels.decays with increasing fluence levels, indicating that for
September/October 2006  Vol. 1154
Use: http://spiedigitallibrary.org/ss/termsofuse.aspx
Yaqoob et al.: Molecular contrast optical coherence tomography…
Downloaded higher e.g.,10 kJ/cm2 fluence levels, B,cum will tend
toward a final value B,cum,final. We note that the final cumu-
lative probability of photobleaching, B,cum,final, would be
representative of the whole photobleaching event.
We also studied the photobleaching phenomenon as a func-
tion of ICG concentrations in DI water. To keep the initial
transmissions alike for different concentrations of ICG, cu-
vettes with different path lengths were assembled. ICG con-
centrations ranging from 12 to 137 M were used in the
study. The irradiance on each sample was 33 W/cm2. For
each concentration, four sets of measurements were acquired
and averaged for better accuracy. The transmission curves
were processed to determine cumulative probability of pho-
tobleaching versus time. The study shows that although
B,cum,init decreases with increasing ICG concentration M see
Fig. 6, where a decrease in B,cum,init with increasing dye
concentration can be clearly seen, the corresponding
B,cum,final values at 10 kJ/cm2 fluence level converge to
2.7±0.610−6. This trend indicates that for high fluence
Fig. 5 Cumulative probability B,cum for 50-M ICG in DI water, 1%
BSA, and 0.8% agarose. The irradiance in all cases is 33.55 W/cm2.
Fig. 6 Initial cumulative probability of photobleaching B,cum,init ver-
sus ICG concentration.
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the extent of photobleaching in 200 and 400 M ICG con-
centrations used in the MCOCT demonstrations. During this
study, we also found the initial probability of photobleaching
for 10 M ICG concentration in water to be110−5,
which is approximately two orders of magnitude smaller than
that reported in Ref. 28.
To estimate the extent of photobleaching in a given sample
of ICG for a specified irradiance I, consider a simple model
that takes into account only the ground, excited, and bleached
states see Fig. 1. The relevant rate equations can therefore
be written as
NE
t
=
GI
h
NG −
1
E
NE, 3a
NB
t
=
B,cum
E
NE, 3b
I
z
= − GN0I + G − BNBI , 3c
where, NG, NE, and NB are the population densities in the
ground, excited, and bleached states, respectively. I is the ir-
radiance, E is the lifetime of excited state, and h is the
energy of photons. Since NE /tNE /E and the irradiance I
is much less than saturation intensity of the excited state, Eqs.
3a and 3b can be combined to yield
NB
t
= B,cum
GI
h
N0 − NB . 4
Notice that irradiance I as well as population densities NG,
NE, and NB are functions of depth z as well as time t. If NBt
represents the spatial average of the bleached state population
density varying in time, differential equation 3c can be
solved as
Iz = I0 exp− GN0 + B − GNBtz , 5
where I0 is the illumination intensity at z=0. Notice that for
small dye concentrations and path length z, one can effec-
tively assume Iz= I0. Since the probability of photobleach-
ing B,cum also changes with time due to its dependency on
fluence, we can use B,cum,final to estimate the extent of pho-
tobleaching in a given sample of ICG. A simplified expression
for photobleached population density NBt can therefore be
determined from Eq. 4 as
NBt = N0	1 − exp− B,cum,finalGI0h t
 . 6
Using B,cum,final=2.710−6 in Eq. 6, the bleached state
population density NBt was estimated for 200 and 400 M
concentrations of ICG in water. The representative curves
shown in Fig. 7 were produced for different irradiances. In
each case, the irradiance on the ICG samples was assumed
uniform through the sample depth z. Notice that in a highly
scattering sample, the approximation Iz= I0 will not hold
and the above expression will overestimate the extent of pho-
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model given by Eq. 6 will help estimating a lower bound
on the time required to photobleach a given sample of ICG.
Notice that representative curves in Figs. 7a and 7b look
Fig. 7 Estimated bleached state population density NBt for a
200 M and b 400 M ICG concentrations for different irradiances.
Fig. 8 a Pump-probe MCOCT setup using a high power broadband
signal acquisition as well as ICG photobleaching. b Timing diagram
single mode fiber; PFOA: programmable fiber-optic attenuator; FC: fiber col
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sections for 200 and 400 M ICG concentrations in water
are comparable. It can also be estimated from Fig. 7 that for
the above concentrations of ICG in water, 7 kW/cm2 irradi-
ance would require approximately 1 s to completely pho-
tobleach 200 and 400 M ICG samples.
3 Pump-Probe MCOCT Setup
Figure 8a shows our spectral domain MCOCT setup. The
experiment uses a high power broadband light source, a
galvoscanner-based programmable fiber-optic attenuator
PFOA, and a single 22 fiber-optic coupler. The PFOA is
an important element in the design of this pump-probe
MCOCT setup as it controls the amount of light reaching the
sample during ICG photobleaching as well as OCT signal
acquisition. A personal computer both controls the PFOA and
acquires data from the spectrometer. Figure 8b shows the
timing diagram of the pump-probe scheme in Fig. 8a. From
an operational point of view, the PFOA is first set to deliver
low optical power, typically less than 100 W, so that pho-
tobleaching is minimal during the first OCT scan. After the
first OCT scan is acquired at time t1, the PFOA is set to
deliver high power, typically a 1000-fold increase, for a du-
ration t to photobleach the ICG. The optical power transmit-
ted by the PFOA is then reduced to the same level as for the
first OCT scan to acquire the second OCT scan at time t2.
At the interferometer, the light collected from the reference
and sample arms is spectrally dispersed using a diffraction
grating and detected using N different detectors. N can vary
from 100 to 1000 s depending upon the spectrometer em-
ployed. For the spectral domain MCOCT setup shown in Fig.
8a, the spectrally resolved interferometric OCT signal can
be mathematically expressed as
Pinterfererncek,z = 2Sk	k1 − 	kRRRs
,z
exp−
0
z
a
,zs + s
,zsdzs
cos2kz − zr , 7
where k is the optical wave number, Sk is the source spec-
e such as Ti:sapphire and a galvoscanner-based PFOA for both OCT
he proposed pump-probe scheme. PC; polarization controller; SMF:sourc
for tlimator.
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coupler 1/2 in an ideal case, RR is the reflectivity of the
reference mirror, Rs
 ,z is the sample reflectivity at depth z,
and z−zr is the path length difference between the reference
arm mirror and the plane of interest inside the sample.
a
 ,z and s
 ,z are the absorption and scattering coef-
ficients, respectively, of the sample at depth z. Moreover, the
period of the spectral oscillation of the measured signal in k
space is proportional to z−zr indicating that an interface
with a smaller z−zr value will produce a slower sinusoidal
spectral oscillation than an interface with a larger z−zr
value. Therefore, a Fourier transform of the spectral measure-
ment will produce a line scan profile also known as an
A-scan of the sample under study. The additional exponential
term accounts for the loss of collected light due to absorption
and scattering during the passage into and out of the sample.
In a pump-probe scheme such as the one discussed above
using ICG as the contrast agent, the photoillumination perma-
nently alters the absorption coefficient of the dye. In this con-
text, the absorption coefficient can be mathematically written
as
a
,z = a,intrinsic
,z + a,ICG_ground
,z + a,ICG
,z ,
8
where a,intrinsic
 ,z is the localized intrinsic absorption co-
efficient of the sample, a,ICG_ground
 ,z is the localized ab-
sorption coefficient component for ICG in the ground state,
and a,ICG
 ,z is the change in the absorption coefficient
between the two OCT scans. The two quantities,
a,ICG_ground
 ,z and a,ICG
 ,z can be expressed as
a,ICG_ground
,z = G
N0z , 9
a,ICG
,z = a,ICG_bleached
,z − a,ICG_ground
,z
=G
NGz + B
NBz − G
N0z ,
10
where G
 and B
 are the ground and bleached state
absorption cross-section spectra, respectively. N0z is the ini-
tial ground state population density of ICG at z, whereas
NGz and NBz are the ground and bleached state population
densities, respectively, when the second OCT scan is ac-
quired. As the irradiance I is much less than saturation inten-
sity of the excited state, NGzNEz, we can safely assume
that N0z=NGz+NBz. Therefore, Eq. 10 can be simpli-
fied as
a,ICG
,z = B
 − G
NBz . 11
If Pinterference_ground
 ,z and Pinterference_bleached
 ,z are the
OCT signals acquired before and after the photobleaching of
ICG, the change in absorption coefficient is related to the two
OCT scans by
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0
z
a,ICG
,zdz = − lnPinterferernce_bleachedk,zPinterferernce_groundk,z  .
12
Solving Eqs. 11 and 12 simultaneously, the distribution of
ICG within the sample, represented by NBz, can be deter-
mined as
NBz =
d
dz 1G
 − B
 lnPinterferernce_bleachedk,zPinterferernce_groundk,z  .
13
4 Experiment
A spectral domain MCOCT system shown in Fig. 8a was
realized for demonstration. Light from a mode locked Ti:sap-
phire laser 12 nm full width at half maximum FWHM is
coupled into a long 5/125 m single mode fiber SMF for
spectrum broadening. The broadband probe light 60 nm
FWHM centered at 800 nm from the SMF is coupled into a
22 single mode fiber-optic coupler via a galvoscanner-
based PFOA. Light from the coupler is collimated by lens
L1f1=11 mm. A 10 microscope objective lens f2
=16.5 mm from Newport Corp. is used to focus the colli-
mated light onto the sample. The calculated 1/e2 beam diam-
eter on the sample is 8.2 m, which corresponds to a depth of
focus of 135 m. Light collected from the two arms of the
interferometer is detected by a spectrometer designed and
built in our laboratory. The spectrometer uses a
1200 lines/mm diffraction grating together with 2048 pixels
linear detector array and features 0.07 nm spectral resolution.
The spectral oscillation data acquired by the spectrometer are
first rescaled and resampled evenly in k space, before it is
Fourier transformed to retrieve the sample depth profile or
A-scan. The rescaled and resampled data are also processed
to adjust for any dispersion mismatch between the two arms
of the interferometer using the method outlined in Ref. 30.
Our laboratory MCOCT system features a measured signal-
to-noise ratio SNR of 98 dB at 1-ms integration time. The
corresponding theoretical shot noise limited SNR is
108 dB.
In a proof-of-concept demonstration, a 0.84 mm path
length glass cuvette filled with 200 M N0=12
1016 cm−3 ICG solution in 1% BSA was used as a sample
see Fig. 9a. The galvoscanner-based PFOA was pro-
grammed to deliver 68 W and 10 mW 19 kW/cm2 irra-
diance based on a beam spot diameter of 8.2 m on the
sample for OCT signal acquisition and ICG photobleaching,
respectively. The linear detector array integration time for
OCT signal acquisition was set to 400 s. The ICG was pho-
tobleached for duration t=2.5 s between the two OCT
scans. Figure 9b shows the two A-scans of the 0.84 mm path
length cuvette filled with 200 M ICG solution in 1% BSA
before and after the photobleaching. The first two interfaces
of the glass cuvette show no contrast as expected. However,
the third and fourth interfaces of the glass cuvette show
7 dB of measured contrast, attributable to the change in
absorption coefficient of the ICG solution within the cuvette.
Next, the 0.84 mm path length glass cuvette was filled with a
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crospheres. A series of 10 A-scans was acquired and pro-
cessed. Figure 9c shows averaged A-scans of the glass cu-
vette before and after the photobleaching. Again, the first two
interfaces show no contrast as anticipated. The last two inter-
faces of the glass cuvette yield a measured contrast of 5 dB.
Notice that the contrast increases with ICG sample depth as it
is cumulative in nature see Eq. 12. A ratio of the two
averaged A-scans is shown in Fig. 9d to support the argu-
ment. Using Eq. 13, average bleached state population NB of
ICG molecules within the cuvette was determined to be
91016 cm−3. We note that at 19 kW/cm2 irradiance, it
should take less than 0.5 s to photobleach 99% of the ICG
molecules see Fig. 7. However, only 75% ICG molecules
were observed to have transitioned to the photobleached state
with an irradiation time of 2.5 s. The reason not all the ICG
molecules were bleached can be attributed to the irradiance
Fig. 9 a Side view of a 0.84 mm path length cuvette used as a sample
before and after the photobleaching. c A-scans of the glass cuvette
0.1 m latex microspheres before and after the photobleaching. d Rdecay through the highly scattering sample 0.25% v/v
Journal of Biomedical Optics 054017-
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molecules to and from the region of interest.
Tissue phantoms as well as an animal model were also
used in order to evaluate ICG as a contrast agent in the pump-
probe–based MCOCT scheme. In these MCOCT demonstra-
tions, the ICG was used with agarose to reduce the effects due
to the diffusion of ICG molecules. In our estimation of pump
light dosage for photobleaching of ICG in agarose, it was
assumed that B,cum,final is approximately the same as that for
ICG in water. This approximation is fairly reasonable since
a the initial probabilities of photobleaching for ICG in water
and agarose are only different by less than a factor of 2 and
b B,cum decreases with fluence in a similar fashion for both
the cases see Fig. 5. Therefore, by approximating
B,cum,final=2.710−6 in Eq. 6, it is estimated that
19 kW/cm2 irradiance would require less than 0.5 s to pho-
tobleach 99% of the ICG molecules in 400 M ICG
-scans of the glass cuvette filled with 200 M ICG solution in 1% BSA
ed with a mixture of 200 M ICG and 0.25% volume concentration
the two A-scans is shown in c.. b A
was fill
atio ofsample in agarose.
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vette comprised of three cells see Figs. 10a and 10b for
side and front views, respectively. Each of the three cells was
filled with a mixture containing 0.25% v/v 0.1 m latex
microspheres, and 0.64% v/v agarose. Cells i and ii also
contained 400 M ICG N0=241016 cm−3 dissolved in
0.5% BSA and DI water, respectively, whereas the third cell
marked iii contained additional 0.125% v/v 1.437 m
latex microspheres in order to bring the total attenuation of
the cell contents close to that of the mixtures in i and ii.
To acquire B-scans two-dimensional 2D images, the
glass cuvette was mounted on a motorized linear stage in
order to move the sample under the probe beam. The PFOA
was programmed such that light exposure levels at the glass
cuvette for OCT signal acquisition and ICG photobleaching
were 60 W and 10 mW, respectively. The linear detector
array integration time per A-scan was set to 1 ms. First, a
B-scan image composed of 600 A-scans was acquired with a
20 m lateral scan step see Fig. 10c. During the second
B-scan, the sample was also photobleached using
19 kW/cm2 irradiance at each A-scan position. Although
the estimated time to photobleach the 400 M ICG samples
was less than 0.5 s, due to irradiance decay through the highly
scattering phantoms as noted earlier we had to increase the
exposure time for effective photobleaching. In summary, the
phantoms were photobleached for t=10 s duration at each
A-scan location during the second B-scan, which is shown in
Fig. 10d. During both B-scans, an OCT sample size of 50
repeats was acquired at each A-scan position in order to re-
duce speckle. A comparison of Figs. 10c and 10d shows
that cells marked as i and ii containing samples of ICG in
0.5% BSA and water, respectively, show significant increase
in backscatter from the latex microspheres. This enhanced
backscatter is attributable to change in absorption coefficients
of the ICG samples in the first two cells. Figure 10e shows
averaged A-scans at the marked location in cell ii before
and after the photobleaching; the corresponding ratio of the
averaged A-scans is shown in Fig. 10g. Using Eq. 13, the
average bleached state population densityNB of ICG mol-
ecules within cell ii was determined as 231016 cm−3,
indicating that 95% ICG molecules were transitioned to the
photobleached state. The third cell marked iii showed no
change in backscatter also see Figs. 10f and 10h for rep-
resentative A-scans and their ratio at the marked location
indicating that regions without ICG do not yield any contrast
in the proposed pump-probe scheme for MCOCT.
To demonstrate the ICG detection capability in an animal
model, a mixture of 400 M ICG, 0.25% v/v 0.1 m latex
microspheres, and 0.6% v/v of agarose was used to fill the
gill arch cavities of euthanized stage 54 Xenopus laevis see
Fig. 11a. First, the PFOA was set to illuminate the sample
with 60 W and a whole B-scan 400 A-scans; lateral reso-
lution 7.5 m was acquired by moving the sample with a
motorized linear stage see Figs. 11b and 11d. During the
second B-scan, the PFOA was set to illuminate the sample
with 10 mW power at each A-scan position for 12 s dura-
tion. The optical power was then readjusted to 60 W to
acquire the corresponding A-scan, and so forth. During both
B-scans, an OCT sample size of 50 repeats was acquired at
each A-scan position in order to reduce speckle. Figures 11c
Journal of Biomedical Optics 054017-
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ter from the microspheres indicating the localization of ICG
in gill arch cavities can be clearly seen. This increased back-
scatter, attributable to the change in the absorption coefficient
of ICG from within the gill arch cavities of the tadpole, dem-
onstrates the functionality of ICG as a contrast agent in the
proposed pump-probe scheme. Further analysis of the xeno-
pus images to estimate achieved contrast could not be carried
out due to sample shifting between the two B-scans acquired
before and after the photobleaching.
5 Considerations of ICG-Based Pump-Probe
Scheme for Clinical Applications
This MCOCT scheme can be applied in animal model studies
to tomographically visualize body cavities, blood vessel sys-
tems, and gastrointestinal tracts. The fact that ICG is approved
for clinical usage points to possible usage of this MCOCT
scheme for clinical applications as well. While the sensitivity
achieved in our study is insufficiently high for clinical appli-
cations, the findings of our study do form a basis by which we
can evaluate the improvements needed for this MCOCT
scheme and other similar MCOCT schemes to be clinically
applicable.
There are two major considerations that we need to ac-
count for. First, is it possible to deliver the fluence needed for
photobleaching in a reasonable time frame? Second, is the
method sufficiently sensitive?
The time frame for fluence delivery can be estimated by
the following approach. The American National Standards In-
stitute ANSI guidelines for skin exposure31 suggest that an
acceptable light illumination for long time frame exposure is
300 mW/cm2. For a nominal ICG concentration of 10 M,
the approved ICG concentration in blood for clinical
procedures,32 photobleaching of 25% of the dye will require a
time duration of 350 s. This time frame can be reduced by
using a higher irradiance or switching to a dye with a higher
quantum yield for photobleaching. This estimate implies that
using ICG with this MCOCT scheme is not well-suited for
time critical clinical procedures.
The sensitivity of the method can be estimated by noting
that the fundamental limit on the contrast agent sensitivity is
related to the SNR of the underlying OCT system as22
SNRMCOCT = 	PsTh 
 Rzexp− 20
z
a,s
,zdz
 azL2, 14
where,  is the detection sensitivity, Ps is the collected sample
power, T is integration time, and h is the energy of photons.
Rz is the sample reflectivity at depth z, whereas a,s is the
overall absorption and scattering extinction coefficient. a
represents the change in absorption coefficient of the thin ab-
sorptive layer of thickness L at depth z inside the scattering
sample. The fundamental limit on the contrast agent sensitiv-
ity can be determined by setting Eq. 14 equal to 1. To de-
termine the minimal concentration of ICG detectable by our
MCOCT system, we use the measured OCT SNR of 98 dB at
1 ms integration time. By assuming a nominal Rz=10−4
typical scattering from tissue, we find out that the minimal
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Downloaded Fig. 10 a Side and b front view of a cuvette composed of 3 cells filled with a mixture containing 0.25% v/v 0.1 m latex microspheres and
0.64% v/v agarose. Cells i and ii also contained 400 M ICG dissolved in 0.5% BSA and DI water, respectively. Cell iii contained additional
0.125% v/v 1.437 m latex microspheres to bring the total attenuation of the cell contents close to that of the mixtures in i and ii. c and d
show B-scan images 600 A-scans each of the glass cuvette, shown in a, acquired with 20 m lateral scan step before and after ICG pho-
tobleaching, respectively. e and g show averaged A-scans of cells ii and iii before and after high intensity illumination, respectively, at the
locations marked by dotted lines; the corresponding ratios of the averaged A-scans are shown in f and h.
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z=0 is 0.8 M. This concentration compares very favorably
with the clinically safe ICG concentration of 10 M in
blood.32
Our experiments show that this sensitivity is not reached
because the above analysis assumes that the OCT signal does
not show significant variation from scan to scan. While this
assumption is true for immobile targets, the presence of fluid
and the associated speckle fluctuations lead to significant
scan-to-scan signal variation. This variation can be as large as
4 to 5 dB from scan to scan in our experiments. While aver-
aging can help reduce the variation, this variation limited our
ability to discern contrast. The reduction of speckle fluctua-
tions is crucial to enabling this and similar MCOCT schemes
to reach the contrast sensitivity given in the above analysis.
6 Conclusions
In conclusion, we have proposed a pump-probe scheme for
MCOCT imaging of biological samples using ICG as a con-
trast agent. The photobleached state in ICG is permanent in
nature that makes this transition useful in the reported pump-
probe scheme. A photobleaching study of 50 M ICG solu-
tions in DI water, BSA, and agarose shows that the cumula-
tive probability of photobleaching decreases with fluence in
all the cases. Various concentrations ranging from 12 to
137 M of ICG in DI water were also studied, which illus-
trates that B,cum,init decreases with the increasing dye con-
centration. We also found that at higher fluence levels, the
final values of cumulative probability for the range of ICG
concentrations used in the study tend to converge to
2.7±0.610−6. The final cumulative probability B,cum,final
Fig. 11 Color online only MCOCT imaging of a stage 54 Xenopus
green, 0.25% 0.1 m latex microspheres, and 0.6% volume concen
acquired. b and c show B-scan images of the illuminated region b
images of gill arch cavities of another stage 54 Xenopus laevis. Increais useful in estimating the extent of photobleaching in a given
Journal of Biomedical Optics 054017-1
From: http://biomedicaloptics.spiedigitallibrary.org/ on 10/05/2016 Terms of sample of ICG for known irradiance and exposure time. Using
our laboratory spectral domain MCOCT setup, we have suc-
cessfully mapped the distribution of ICG 400 M concentra-
tion within tissue phantoms as well as stage 54 Xenopus lae-
vis. The ability to detect and map depth-resolved distribution
of ICG within a biological sample illustrates the potential of
the proposed pump-probe scheme to provide high resolution
structural information of tissue as well as the ability to differ-
entiate between certain tissue pathologies.
As opposed to spectral triangulation MCOCT,20 which is
based on spectral differential absorption of ICG, the proposed
pump-probe scheme relies upon the change in absorption
spectrum of ICG due to photobleaching. Since the proposed
method uses the permanently photobleached state in ICG the
photobleached dye molecules do not relax back to the ground
state, both the optical design as well as the associated data
acquisition methodology are simple.
However, the proposed technique does rely on its ability to
effectively photobleach the dye. The current pump-probe
MCOCT scheme is limited in imaging speed due to the low
probability of photobleaching, which requires high irradiance
and relatively long exposure time to photobleach ICG. For
instance, the estimated light exposure level required for com-
plete photobleaching of 10 M ICG is 4 to 5 orders of mag-
nitude higher than the ANSI prescribed limits. Previously, it
has been shown that the probability of ICG photobleaching
decreases in the presence of certain materials such as silver
particles. A study of materials that would potentially increase
the probability of ICG photobleaching upon conjugation
would benefit the proposed ICG-based pump-probe MCOCT
scheme. Using higher irradiance subject to the availability of
a Ventral view of the animal filled with a mixture of 400 M ICG
of agarose; the red line indicates the region where OCT scans were
and after ICG photobleaching, respectively. d and e show B-scan
ckscatter from within the gill arch cavities of the animal can be seen.laevis.
tration
efore
sed bahigh power light source and modifying the system accord-
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Downloaded ingly, so as to photobleach the entire region of interest as
opposed to line-by-line photobleaching the current method-
ology, we can improve the overall imaging speed of the sys-
tem.
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